You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Fougera Pharms Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for FOUGERA PHARMS INC, and what generic and branded alternatives to FOUGERA PHARMS INC drugs are available?

FOUGERA PHARMS INC has twenty-nine approved drugs.

Summary for Fougera Pharms Inc
US Patents:0

Drugs and US Patents for Fougera Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms Inc CLOBETASOL PROPIONATE clobetasol propionate CREAM;TOPICAL 074392-001 Sep 30, 1996 AB1 RX No No ⤷  Sign Up ⤷  Sign Up
Fougera Pharms Inc TAZAROTENE tazarotene CREAM;TOPICAL 211175-001 Jan 28, 2019 DISCN No No ⤷  Sign Up ⤷  Sign Up
Fougera Pharms Inc BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 018865-001 Aug 31, 1983 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up
Fougera Pharms Inc GENTAMICIN SULFATE gentamicin sulfate CREAM;TOPICAL 062531-001 Jul 5, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.